Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype.

Publication Year: 2022

DOI:
10.1016/j.neo.2022.100830

PMCID:
PMC9386102

PMID:
35939881

Journal Information

Full Title: Neoplasia

Abbreviation: Neoplasia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Amber de Groot: Conceptualization, Methodology, Investigation, Writing - Original Draft, Writing - Review & Editing, Visualization. Kayla Myers: Conceptualization, Methodology, Investigation, Writing - Original Draft, Writing - Review & Editing, Visualization. Timothy Krueger: Methodology. W. Nathaniel Brennen: Methodology, Funding acquisition. Sarah Amend: Conceptualization, Writing - Review & Editing, Supervision, Funding acquisition. Kenneth Pienta: Conceptualization, Writing - Review & Editing, Supervision, Funding acquisition"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025